Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Titanium dioxide nanoparticles may harm the male reproductive system.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Genetic factors, including a variant near the FGF5 gene, contribute to hirsutism and are linked to PCOS and metabolic traits.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

The questionnaire is valid and reliable but needs more testing for future predictions.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Different parts of the body's fat tissue have unique cell types and characteristics, which could help treat chronic wounds.

SLC3A2 is crucial for hair follicle stem cell function and hair growth.

PCOS may be linked to spina bifida in young females.

Wnt signaling can improve skin healing by promoting epithelial growth.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.